Search research articles
Contact Us
Filters
Showing results (1-10 of 220) with videos related to
Page
of 22
Sort By:
Journal of the American Society of Nephrology : JASN
|
April 13, 2007
Autosomal dominant polycystic kidney disease: time for a change?
Arlene B Chapman
Clinical Journal of the American Society of Nephrology : CJASN
|
June 27, 2008
Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies
Arlene B Chapman
Kidney360
|
November 22, 2023
All Patients with ADPKD Should Undergo Screening for Intracranial Aneurysms: COMMENTARY
Arlene B Chapman
Kidney International
|
February 4, 2014
The importance of quantifying genetic heterogeneity in ADPKD
Arlene B Chapman
Advances in Renal Replacement Therapy
|
March 5, 2003
Cystic disease in women: clinical characteristics and medical management
Arlene B Chapman
Kidney International
|
April 14, 2012
The fetal environment: a critical phase that determines future renal outcomes in autosomal dominant polycystic kidney disease
Arlene B Chapman
Kidney International
|
January 1, 2009
Improving clinical trial design for inquiries into the mechanisms of cyst growth in ADPKD
Arlene B Chapman
Kidney International
|
January 31, 2015
Does dopamine connect the dots in ADPKD?
Arlene B Chapman
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
May 25, 2015
Acute Response to Tolvaptan in ADPKD: A Window to Predict Long-term Efficacy?
Bharathi Reddy, Arlene B Chapman
Seminars in Nephrology
|
July 26, 2011
Imaging approaches to patients with polycystic kidney disease
Arlene B Chapman, Wenjing Wei
Page
of 22
Search research articles
Search
Showing results (1-10 of 220) with videos related to
Sort By:
Page
of 22
Journal of the American Society of Nephrology : JASN
|
April 13, 2007
Autosomal dominant polycystic kidney disease: time for a change?
Arlene B Chapman
Clinical Journal of the American Society of Nephrology : CJASN
|
June 27, 2008
Approaches to testing new treatments in autosomal dominant polycystic kidney disease: insights from the CRISP and HALT-PKD studies
Arlene B Chapman
Kidney360
|
November 22, 2023
All Patients with ADPKD Should Undergo Screening for Intracranial Aneurysms: COMMENTARY
Arlene B Chapman
Kidney International
|
February 4, 2014
The importance of quantifying genetic heterogeneity in ADPKD
Arlene B Chapman
Advances in Renal Replacement Therapy
|
March 5, 2003
Cystic disease in women: clinical characteristics and medical management
Arlene B Chapman
Kidney International
|
April 14, 2012
The fetal environment: a critical phase that determines future renal outcomes in autosomal dominant polycystic kidney disease
Arlene B Chapman
Kidney International
|
January 1, 2009
Improving clinical trial design for inquiries into the mechanisms of cyst growth in ADPKD
Arlene B Chapman
Kidney International
|
January 31, 2015
Does dopamine connect the dots in ADPKD?
Arlene B Chapman
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
May 25, 2015
Acute Response to Tolvaptan in ADPKD: A Window to Predict Long-term Efficacy?
Bharathi Reddy, Arlene B Chapman
Seminars in Nephrology
|
July 26, 2011
Imaging approaches to patients with polycystic kidney disease
Arlene B Chapman, Wenjing Wei
Page
of 22